Alexandra Drakaki

New Capabilities

Called for longer follow-up on the three-drug arm

About half of people with muscle-invasive bladder cancer cannot receive cisplatin, the chemotherapy normally given before surgery to reduce the chance the cancer returns. Those patients have generally gone straight to bladder removal. A 695-patient international trial now shows a chemotherapy-free drug pair given before surgery lowers the risk of death by 42%.

Updated 1 hour ago